Position in MRK
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$2,251,030,425
+$233,772,427 QoQ
Shares Held
18,713,363
-2.4% QoQ
Ownership
0.758%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 89.28223109870737.ToString("F0")%
Shared 0.7632513728291381.ToString("F0")%
None 9.954517528463484.ToString("F0")%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $22,910,045,373 across 16 Drug Manufacturers - General names. MRK ranks #4 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
21,821,962 | $5,334,160,377 | |
| 2 | LLY |
ELI LILLY & Co
|
4,860,408 | $4,470,457,455 | |
| 3 | ABBV |
AbbVie Inc.
|
13,278,161 | $2,887,867,228 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
18,713,363 | $2,251,030,425 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
15,053,151 | $2,097,957,640 | |
| 6 | PFE |
Pfizer Inc
|
53,879,900 | $1,512,947,580 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
23,301,337 | $1,413,226,077 | |
| 8 | AMGN |
Amgen Inc
|
3,793,443 | $1,334,722,908 |
All Filings in MRK
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,251,030,425 | 18,713,363 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $2,017,257,998 | 19,164,526 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,829,200,122 | 21,794,354 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $1,741,316,550 | 21,997,430 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $2,076,225,714 | 23,130,857 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $2,408,762,653 | 24,213,537 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $2,119,337,680 | 18,662,713 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $2,371,053,494 | 19,152,290 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $2,591,885,796 | 19,642,939 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $2,270,878,523 | 20,829,926 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $2,572,963,145 | 24,992,357 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $3,082,909,468 | 26,717,302 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $3,101,159,759 | 29,148,978 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $3,372,395,028 | 30,395,629 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,673,958,041 | 31,049,211 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,970,361,898 | 32,580,475 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,690,626,913 | 32,792,528 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $2,373,574,821 | 30,970,444 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,203,283,192 | 29,334,086 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $2,303,571,112 | 29,620,305 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $2,248,743,575 | 30,570,528 | Shares | Other | 2021-05-13 | |
| 2020-09-30 | $2,598,239,218 | 32,826,443 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $2,329,041,881 | 31,563,880 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $2,556,348,122 | 34,820,041 | Shares | Other | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||